TJAP1_HUMAN - dbPTM
TJAP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TJAP1_HUMAN
UniProt AC Q5JTD0
Protein Name Tight junction-associated protein 1
Gene Name TJAP1
Organism Homo sapiens (Human).
Sequence Length 557
Subcellular Localization Golgi apparatus. Cell junction, tight junction. Recruited to tight junctions (TJ) during late stages of maturation of the TJ complexes. Excluded from adherens junctions and desmosomes (By similarity)..
Protein Description
Protein Sequence MTSAAPAKKPYRKAPPEHRELRLEIPGSRLEQEEPLTDAERMKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKFKDKFRRLQNSYTASQRTNQELEDKLHTLASLSHSWIFAIKKAEMDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNLAVQLLKCNKSHFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIARVLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEEELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKRMGVHHLHRKDSLTQAQEQGNLLN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MTSAAPAKK
------CCCCCCCCC
27.3722814378
3Phosphorylation-----MTSAAPAKKP
-----CCCCCCCCCC
22.5724719451
11PhosphorylationAAPAKKPYRKAPPEH
CCCCCCCCCCCCHHH
33.3624719451
28PhosphorylationLRLEIPGSRLEQEEP
EEEECCCCHHCCCCC
28.47-
37PhosphorylationLEQEEPLTDAERMKL
HCCCCCCCHHHHHHH
43.83-
58PhosphorylationELRRRLASATRRTEA
HHHHHHHHHHHHHHH
34.4622817900
60PhosphorylationRRRLASATRRTEALE
HHHHHHHHHHHHHHH
20.4223312004
63PhosphorylationLASATRRTEALEREL
HHHHHHHHHHHHHHH
23.48-
147 (in isoform 2)Phosphorylation-4.41-
155UbiquitinationTNKLLDAKNTINKLE
HHHHHHHHHHHHHHH
55.05-
157PhosphorylationKLLDAKNTINKLEEL
HHHHHHHHHHHHHHH
25.8123403867
160UbiquitinationDAKNTINKLEELNER
HHHHHHHHHHHHHHH
54.12-
198 (in isoform 2)Phosphorylation-7.15-
204UbiquitinationELQDMVRKHLHSGQE
HHHHHHHHHHHCCCC
38.82-
208PhosphorylationMVRKHLHSGQEAASP
HHHHHHHCCCCCCCC
48.8321712546
214PhosphorylationHSGQEAASPGPAPSL
HCCCCCCCCCCCCCC
37.1225159151
220PhosphorylationASPGPAPSLAPGAVV
CCCCCCCCCCCCCCC
38.9920873877
229PhosphorylationAPGAVVPTSVIARVL
CCCCCCCHHHHHHHH
24.8223312004
230PhosphorylationPGAVVPTSVIARVLE
CCCCCCHHHHHHHHH
12.8823312004
290 (in isoform 2)Phosphorylation-35.38-
293PhosphorylationQPNGECHSLGTARGS
CCCCCCCCCCCCCCC
39.9026074081
296PhosphorylationGECHSLGTARGSPEE
CCCCCCCCCCCCCHH
20.6226074081
300PhosphorylationSLGTARGSPEEELPL
CCCCCCCCCHHCCCC
24.4719664994
308 (in isoform 2)Phosphorylation-32.72-
310 (in isoform 2)Phosphorylation-8.86-
316PhosphorylationAFEKLNPYPTPSPPH
HHHHCCCCCCCCCCC
20.7522167270
316 (in isoform 2)Phosphorylation-20.75-
318PhosphorylationEKLNPYPTPSPPHPL
HHCCCCCCCCCCCCC
30.4722167270
320PhosphorylationLNPYPTPSPPHPLYP
CCCCCCCCCCCCCCC
54.2422167270
326PhosphorylationPSPPHPLYPGRRVIE
CCCCCCCCCCCCEEE
14.2122167270
335PhosphorylationGRRVIEFSEDKVRIP
CCCEEECCCCCCCCC
31.9021815630
335 (in isoform 2)Phosphorylation-31.90-
345PhosphorylationKVRIPRNSPLPNCTY
CCCCCCCCCCCCCCH
29.1521945579
351PhosphorylationNSPLPNCTYATRQAI
CCCCCCCCHHHHHHH
23.8821945579
352PhosphorylationSPLPNCTYATRQAIS
CCCCCCCHHHHHHHE
14.2621945579
354PhosphorylationLPNCTYATRQAISLS
CCCCCHHHHHHHEEH
16.9521945579
359PhosphorylationYATRQAISLSLVEEG
HHHHHHHEEHHHHCC
18.2122199227
361PhosphorylationTRQAISLSLVEEGSE
HHHHHEEHHHHCCCC
24.4722199227
367PhosphorylationLSLVEEGSERARPSP
EHHHHCCCCCCCCCC
27.4720068231
381PhosphorylationPVPSTPASAQASPHH
CCCCCCCCCCCCCCC
23.3228348404
385PhosphorylationTPASAQASPHHQPSP
CCCCCCCCCCCCCCC
16.8228348404
391PhosphorylationASPHHQPSPAPLTLS
CCCCCCCCCCCEEEE
27.4228348404
398PhosphorylationSPAPLTLSAPASSAS
CCCCEEEECCCCCCC
27.2828348404
402PhosphorylationLTLSAPASSASSEED
EEEECCCCCCCCHHH
25.9427251275
403PhosphorylationTLSAPASSASSEEDL
EEECCCCCCCCHHHH
33.9927251275
405PhosphorylationSAPASSASSEEDLLV
ECCCCCCCCHHHHHH
39.9828348404
406PhosphorylationAPASSASSEEDLLVS
CCCCCCCCHHHHHHH
44.7328348404
412 (in isoform 2)Phosphorylation-7.70-
422PhosphorylationQRAFVDRTPPPAAVA
HHHHHCCCCCHHHHH
35.3729255136
449PhosphorylationLQRHFAHSPADRDEV
HHHHHCCCCCCHHHH
20.5327794612
481 (in isoform 2)Phosphorylation-62.79-
491PhosphorylationEELNLPISPEEERQS
HHHCCCCCHHHHHHC
25.0719664994
504MethylationQSLLPINRGTEEGPG
HCCCCCCCCCCCCCC
54.88115918521
506PhosphorylationLLPINRGTEEGPGTS
CCCCCCCCCCCCCCC
27.8528555341
524PhosphorylationGRAWPLPSSSRPQRS
CCCCCCCCCCCCCCC
48.9423403867
525PhosphorylationRAWPLPSSSRPQRSP
CCCCCCCCCCCCCCC
28.5523403867
526PhosphorylationAWPLPSSSRPQRSPK
CCCCCCCCCCCCCCC
52.9323403867
531PhosphorylationSSSRPQRSPKRMGVH
CCCCCCCCCCCCCCC
29.5322617229
535 (in isoform 2)Phosphorylation-9.08-
537 (in isoform 2)Phosphorylation-1.56-
545PhosphorylationHHLHRKDSLTQAQEQ
CCCCCCHHHHHHHHH
36.0319664994
547PhosphorylationLHRKDSLTQAQEQGN
CCCCHHHHHHHHHCC
26.3029255136

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TJAP1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TJAP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TJAP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DLG1_HUMANDLG1physical
11602598

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TJAP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300 AND SER-545, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-545, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300; THR-318; SER-320;SER-345; THR-422 AND SER-545, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-545, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-352, AND MASSSPECTROMETRY.

TOP